Karex Berhad Balance Sheet Health

Financial Health criteria checks 5/6

Karex Berhad has a total shareholder equity of MYR479.1M and total debt of MYR133.2M, which brings its debt-to-equity ratio to 27.8%. Its total assets and total liabilities are MYR721.5M and MYR242.3M respectively. Karex Berhad's EBIT is MYR35.6M making its interest coverage ratio 4. It has cash and short-term investments of MYR43.5M.

Key information

27.8%

Debt to equity ratio

RM133.19m

Debt

Interest coverage ratio	4x
Cash	RM43.49m
Equity	RM479.14m
Total liabilities	RM242.33m
Total assets	RM721.48m

Recent financial health updates

Karex Berhad (KLSE:KAREX) Is Making Moderate Use Of Debt

Dec 06

Is Karex Berhad (KLSE:KAREX) A Risky Investment?

Feb 22

Recent updates

Karex Berhad (KLSE:KAREX) Just Released Its Full-Year Earnings: Here's What Analysts Think

Aug 31

A Look At The Fair Value Of Karex Berhad (KLSE:KAREX)

Mar 08

Karex Berhad (KLSE:KAREX) Is Making Moderate Use Of Debt

Dec 06

Update: Karex Berhad (KLSE:KAREX) Stock Gained 95% In The Last Year

Mar 15

Is Karex Berhad (KLSE:KAREX) A Risky Investment?

Feb 22

How Much Of Karex Berhad (KLSE:KAREX) Do Insiders Own?

Feb 05

Are Poor Financial Prospects Dragging Down Karex Berhad (KLSE:KAREX Stock?

Jan 18

Does Karex Berhad's (KLSE:KAREX) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 31

What These Trends Mean At Karex Berhad (KLSE:KAREX)

Dec 13

The Karex Berhad (KLSE:KAREX) Share Price Has Gained 96% And Shareholders Are Hoping For More

Nov 22

Financial Position Analysis

Short Term Liabilities: KAREX's short term assets (MYR322.5M) exceed its short term liabilities (MYR177.9M).

Long Term Liabilities: KAREX's short term assets (MYR322.5M) exceed its long term liabilities (MYR64.4M).

Debt to Equity History and Analysis

Debt Level: KAREX's net debt to equity ratio (18.7%) is considered satisfactory.

Reducing Debt: KAREX's debt to equity ratio has increased from 7.5% to 27.8% over the past 5 years.

Debt Coverage: KAREX's debt is well covered by operating cash flow (48.2%).

Interest Coverage: KAREX's interest payments on its debt are well covered by EBIT (4x coverage).

Karex Berhad Balance Sheet Health

Financial Health criteria checks 5/6

Key information

Recent financial health updates

Karex Berhad (KLSE:KAREX) Is Making Moderate Use Of Debt

Is Karex Berhad (KLSE:KAREX) A Risky Investment?

Recent updates

Consensus revenue estimates decrease by 11%, EPS upgraded

Second quarter 2024 earnings released: EPS: RM0.007 (vs RM0.002 in 2Q 2023)

Karex Berhad Announces Resignation of Lim Lee Kuan as Joint Secretary

Karex Berhad Appoints CHOONG SIEW MUN as Company Secretary

Should You Investigate Karex Berhad (KLSE:KAREX) At RM0.81?

Karex Berhad Announces the Single Tier Interim Dividend for the Financial Year Ending 30 June 2024, Payable on January 19, 2024

Insufficient new directors

First quarter 2024 earnings released: EPS: RM0.005 (vs RM0.002 in 1Q 2023)

Karex Berhad Declares First Interim Dividend for the Financial Year Ending 30 June 2024

Karex Berhad Announces Resignation of Elizabeth Allison De Zilva as Joint Secretary

Karex Berhad, Annual General Meeting, Nov 27, 2023

Karex Berhad Announces Appointment of Mr. Chew Fook Aun as Independent and Non Executive Member of Risk Committee

Full year 2023 earnings released: EPS: RM0.01 (vs RM0.006 loss in FY 2022)

Karex Berhad (KLSE:KAREX) Might Not Be As Mispriced As It Looks

Third quarter 2023 earnings released: EPS: RM0.002 (vs RM0.001 loss in 3Q 2022)

Karex Berhad, Annual General Meeting, Jun 08, 2023

Insufficient new directors

Price target increased by 33% to RM0.96

Second quarter 2023 earnings released: EPS: RM0.002 (vs RM0.003 loss in 2Q 2022)

Should You Think About Buying Karex Berhad (KLSE:KAREX) Now?

First quarter 2023 earnings released: EPS: RM0.002 (vs RM0.001 in 1Q 2022)

Price target increased to RM0.72

Price target increased to RM0.72

Full year 2022 earnings: EPS and revenues miss analyst expectations

Karex Berhad, Annual General Meeting, Nov 28, 2022

Calculating The Intrinsic Value Of Karex Berhad (KLSE:KAREX)

Karex Berhad (KLSE:KAREX) Just Released Its Full-Year Earnings: Here's What Analysts Think

Karex Berhad Dato Announces Redesignation of Ong Eng Long as Independent and Non Executive Chairman from Independent and Non Executive Director

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Karex Berhad Announces Demise of Tun Dato' Seri Arshad Bin Ayub, Independent and Non Executive Chairman

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

A Look At The Fair Value Of Karex Berhad (KLSE:KAREX)

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Karex Berhad (KLSE:KAREX) Is Making Moderate Use Of Debt

Independent Non-Executive Director Yien Wong has left the company

Price target decreased to RM0.56

Consensus EPS estimates fall to RM0.007

Third quarter 2021 earnings released: RM0.003 loss per share (vs RM0.001 loss in 3Q 2020)

Price target decreased to RM0.58

Update: Karex Berhad (KLSE:KAREX) Stock Gained 95% In The Last Year

Analysts lower EPS estimates to RM0.016

Is Karex Berhad (KLSE:KAREX) A Risky Investment?

New 90-day low: RM0.76

How Much Of Karex Berhad (KLSE:KAREX) Do Insiders Own?

Are Poor Financial Prospects Dragging Down Karex Berhad (KLSE:KAREX Stock?

Does Karex Berhad's (KLSE:KAREX) Statutory Profit Adequately Reflect Its Underlying Profit?

What These Trends Mean At Karex Berhad (KLSE:KAREX)

New 90-day high: RM0.94

Analysts increase EPS estimates to RM0.019

Karex Berhad Announces Retirement of Jonathan Law Ngee Song as Independent and Non Executive Member of Audit Committee

Price target raised to RM0.80

First quarter 2021 earnings released: EPS RM0.004

The Karex Berhad (KLSE:KAREX) Share Price Has Gained 96% And Shareholders Are Hoping For More

Analysts update estimates

Full year earnings released - EPS RM0.0002

Price target raised to RM0.60

New 90-day high - RM0.67

Financial Position Analysis

Debt to Equity History and Analysis

Balance Sheet

Discover healthy companies